Latest News in the pharma Industry

Top Stories

Cuba Distributes First Lung Cancer Vax in Hospitals without Charge

Cuba Distributes First Lung Cancer Vax in Hospitals without Charge

13 Sep 2011

Cuban medical authorities have launched the distribution of CimaVax-EGF, the world's first lung cancer vaccine, in Cuban hospitals free of charge.

Read more 
Alchemia Starts Phase II Trial in Small Cell Lung Cancer

Alchemia Starts Phase II Trial in Small Cell Lung Cancer

13 Sep 2011

This study will examine the effectiveness of HA-Irinotecan, which utilizes Alchemia's technology to target the anti-cancer drug irinotecan to the tumor.

Read more 
HCN2 Gene Gives Hope to Treat Chronic Pain

HCN2 Gene Gives Hope to Treat Chronic Pain

13 Sep 2011

Researchers has identified a gene responsible for chronic back pain.

Read more 
Lung Disease Therapy Esbriet to be Launched in Germany

Lung Disease Therapy Esbriet to be Launched in Germany

13 Sep 2011

Esbriet will be commercially available in Europe for the first time since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis.

Read more 
BMS Completes Acquisition of Amira

BMS Completes Acquisition of Amira

9 Sep 2011

Bristol-Myers Squibb has completed its previously announced acquisition of small-molecule pharmaceutical company Amira Pharmaceuticals.

Read more 
HHS Awards $94M to GSK for New Antibiotic Development

HHS Awards $94M to GSK for New Antibiotic Development

9 Sep 2011

GlaxoSmithKline will receive $94m from the US Department of Health and Human Services for a promising new antibiotic research and testing.

Read more 
Germany to Invest Billions for Healthcare Research

Germany to Invest Billions for Healthcare Research

8 Sep 2011

The new programme will provide a boost to bringing research results rapidly to market, according to Germany Trade & Invest.

Read more 
BioLineRx Signs License Deal for Pain Treatment BL-7050

BioLineRx Signs License Deal for Pain Treatment BL-7050

8 Sep 2011

BioLineRx announced yesterday its worldwide, exclusive license agreement with Ramot at Tel Aviv University for a neuropathic and inflammatory pain treatment.

Read more 
Merck Serono & F-Star Collaborate for Novel Targeted Biologics

Merck Serono & F-Star Collaborate for Novel Targeted Biologics

8 Sep 2011

Austria's F-Starfor announced yesterday the agreement with Merck Serono for the discovery of new antibody-derived therapeutics against inflammatory disease targets.

Read more 
Evotec & Roche Ink Alzheimer's Pact

Evotec & Roche Ink Alzheimer's Pact

7 Sep 2011

Evotec and Roche have teamed up to develop and commercialize MAO-B inhibitor of Evotec for the patients with Alzheimer's disease.

Read more 
WHO & FIP Sign Landmark Initiative for Tuberculosis Care Improvement

WHO & FIP Sign Landmark Initiative for Tuberculosis Care Improvement

7 Sep 2011

The WHO and the FIP signed a joint statement seeking to involve pharmacists in tuberculosis care and control.

Read more 
Addex Regains Parkinson's Programme Rights from Merck

Addex Regains Parkinson's Programme Rights from Merck

7 Sep 2011

Merck originally licensed the rights to the programme in 2007 in a deal potentially worth as much as $170.5m.

Read more